SCHEMBL19990752

SCHEMBL19990752

COC(=O)c1cc(C(=O)OC)c(C(=O)OC)cc1C=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 4/20 0.44
ALDH1A1 P00352 6/20 0.43
POLB P06746 1/20 0.43
RAB9A P51151 1/20 0.43
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
PDK2 Q15119 1/20 0.41
PDK4 Q16654 1/20 0.41
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
KDM4E B2RXH2 3/20 0.40
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
GAA P10253 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4117648 0.84 ALDH1A1 (0.44) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL31306269 0.84 ERN1 (0.48) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL19998358 0.84 ALDH1A1 (0.44) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL852311 0.82 GAA (0.47) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL23364530 0.82 KDM4E (0.58) ERN1ALDH1A1POLBKDM4ETSHR
SCHEMBL829753 0.82 CA12 (0.54) ALDH1A1POLBCA12CA1CA2
SCHEMBL13473596 0.80 ALDH1A1 (0.50) ERN1ALDH1A1POLBRAB9AHCRTR1
SCHEMBL21574949 0.79 ALDH1A1 (0.40) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL31336100 0.79 ERN1 (0.51) ERN1ALDH1A1POLBRAB9ACA12
SCHEMBL1161943 0.79 ERN1 (0.51) ERN1ALDH1A1POLBRAB9ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3318553-B1 FULLERENE DERIVATIVE AND LUBRICANT SHOWA DENKO KK (JP) 2020-06-17 EP disclosed
EP-3318553-B1 FULLERENE DERIVATIVE AND LUBRICANT SHOWA DENKO KK (JP) 2020-06-17 EP disclosed
US-10336764-B2 Fullerene derivative and lubricant SHOWA DENKO K.K. (JP) 2019-07-02 US disclosed
US-10336764-B2 Fullerene derivative and lubricant SHOWA DENKO K.K. (JP) 2019-07-02 US disclosed
EP-3318553-A1 FULLERENE DERIVATIVE AND LUBRICANT Showa Denko K.K. (JP) 2018-05-09 EP disclosed
EP-3318553-A1 FULLERENE DERIVATIVE AND LUBRICANT Showa Denko K.K. (JP) 2018-05-09 EP disclosed
US-20180086771-A1 FULLERENE DERIVATIVE AND LUBRICANT RESONAC CORPORATION (JP) 2018-03-29 US disclosed
US-20180086771-A1 FULLERENE DERIVATIVE AND LUBRICANT RESONAC CORPORATION (JP) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10336764-B2 Fullerene derivative and lubricant FLNA, MDM4, PFN1 ERN1 3316/4885ALDH1A1 2536/4885POLB 1179/4885
US-20180086771-A1 FULLERENE DERIVATIVE AND LUBRICANT FLNA, MDM4, PFN1 ERN1 3316/4885ALDH1A1 2536/4885POLB 1179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.